| Similar Articles |
|---|
 |
Bio-IT World
October 10, 2003
Robert M. Frederickson |
Capturing Clinical Information Ardais is building a repository of clinical samples and related patient data.   |
Bio-IT World
February 18, 2004 |
Proteomics Goes Cellular Tissue microarrays save big on sample material and reagents. But more importantly, this new high-throughput technology is helping save the lives of cancer patients |
Bio-IT World
February 18, 2004 |
Pathology Goes Molecular New technologies are enabling clinical diagnostic laboratories to pave the way toward more personalized cancer therapies |
Bio-IT World
October 2005
Mark D. Uehling |
HistoRx Automates Pathology The company offers a platform called Aqua, which can perform automated, in situ analysis of protein expression levels on tissue microarrays in less than an hour. The company has promising projects in melanoma and breast cancer. |
Fast Company
January 2002
George Anders |
Roche's New Scientific Method How does a giant pharmaceutical company reckon with genomics technology? By making a fresh start in how it recruits its scientists, manages projects, and uses computers. Here's how the Roche Group is reinventing how it invents... |
Bio-IT World
June 15, 2003
Robert M. Frederickson |
Popular (Tissue) Culture Tissue microarrays are coming into their own as important histological screening tools. |
Bio-IT World
March 17, 2004 |
Pharma's Genomic Harvest How Pfizer plans to meet its goal of 20 new drug applications by 2006. |
Bio-IT World
January 21, 2005
Kevin Davies |
A Vision for iScience Applied Biosystems president Catherine Burzik discusses integrated science, lab technology, and running a $2B business. |
Pharmaceutical Executive
September 1, 2013
Jordan Sarver |
Pathology in the Era of Personalized Medicine With their knowledge of molecular genetics, Pathologists are transforming the way healthcare is provided. |
Bio-IT World
January 21, 2005 |
Defining 'Integrative Genomics' Five experts from academia and industry discuss the burgeoning field of integrative genomics. |
Bio-IT World
November 12, 2002
James Golden |
The Business of Bioinformatics The industry has reached an interesting crossroads. As an academic branch of learning, bioinformatics remains mostly what it always was, a cross-disciplinary endeavor between computer science and molecular biology. But bioinformatics as a money-making proposition has different criteria for success. |
Bio-IT World
July 11, 2002
Malorye Branca |
Deep Sequence Diving Like sailors of old, genomic data miners dream of discovering riches and fame. Given the recent improvements in analytics -- and a little more time -- they just might succeed. |
Bio-IT World
June 2006
Robert M. Frederickson |
Tissue Microarray Hard and Software Technological advances in automated microscopes, digital image acquisition, and high-throughput screening techniques have led to the need for more sophisticated software tools, now offered through a collaboration between DMetrix, BioImagene, IBM and the Arizona Cancer Center. |
Scientific American
October 10, 2005
JR Minkel |
Uninformed Consent Medical donors remain unaware they do not own their cells. To patient advocates, policy implications of the latest court rulings are more important than their legal correctness. |
Bio-IT World
August 2005 |
Project Summaries Summaries of candidates for Bio-IT World's "Best Practices 2005" projects. |
Bio-IT World
November 14, 2003
Malorye Branca |
Genomics Provides the Kick Inside New tools and business structures show signs of plumping early-stage pipelines. |
| Knowledge@Wharton |
From Skin Creams to Life Insurance to Medical Care, Biosciences Are the New Frontier of Business Opportunity Research in the biological sciences holds the potential for breakthroughs that could transform the world. But scientific advances also can be baffling and more than a little intimidating, especially for business people... |
Chemistry World
December 20, 2010
Jennifer Newton |
Frozen assets in biobanks Scientists from Sweden have devised a technique that extracts both DNA and RNA from frozen tissue in a bid to improve large-scale extractions from samples stored in biobanks, which could aid cancer research. |
IEEE Spectrum
September 2006
Michael Dumiak |
Cells on Ice An engineering team prepares for the day when stem cells win public acceptance. |
Fast Company
September 2000
John Ellis |
The Secret of Life The mapping of the human genome, says Craig Venter, will change science, research, medicine, politics, health insurance, and the way biology looks at the last 3 billion years of evolution. And that's just the beginning. |
Bio-IT World
August 13, 2003
John Rhodes |
Beyond the Blockbuster Genomics and big hits are not mutually exclusive, writes Deloitte & Touche's life sciences expert. |
Bio-IT World
August 2005 |
Best Practices 2005 Winners Winners of the Best Practices awards include an innovative drug safety monitoring system, an integrated genomics gateway, and a genotyping pipeline. |
Chemistry World
January 12, 2012
Russell Johnson |
Staining tissue samples at the microscale A vertical microfluidic probe developed by researchers in Switzerland can create a range of immunohistochemistry staining conditions on a single tissue sample. |
Managed Care
August 2007
Thomas Morrow |
Gene Expression Microarray Improves Prediction of Breast Cancer Outcomes Flash-frozen samples of surgically removed breast cancer tissue are the key to measuring a patient's risk of metastasis. |
Bio-IT World
August 15, 2005
John Russell |
Reasons for Optimism Submissions to the 2005 Bio-IT World Best Practices Awards Program included a description of a systems of hieroglyphic representations of proteins, a platform for integrative genomics, and a number of entries that saved man hours by utilizing client management tools. |
Chemistry World
March 18, 2011
Elinor Richards |
The way to pain-free uterine disease detection A potential non-invasive method to detect endometriosis by acquiring a spectral signature of the uterus has been developed by scientists from the UK. |
Reason
March 2007
Kerry Howley |
Who Owns Your Body Parts? In the U.S., demand for human tissue has never been higher, and human remains have never been more valuable. Everyone's making money in the market for body tissue -- except the donors. |
Fast Company
November 1999
John Ellis |
Digital Matters - Issue 29 In My Humble Opinion: Genomics is the most important economic, political, and ethical issue facing mankind. |
Chemistry World
December 11, 2013
Jennifer Newton |
'Google map' of a prostate UK researchers have used vibrational spectroscopy to chemically image the cross section of a prostate to such an incredible level of detail that each of the 66 million pixels in the image represents a piece of tissue only 5.5 A -- 5.5 m. |
Bio-IT World
August 15, 2005
Kevin Davies |
Pimp My Genome As costs plummet, the ability to rapidly synthesize and customize longer, more intricate fragments of genomic DNA opens up a plethora of applications in basic and applied biology. A commercial synthetic biology industry is beginning to take shape. |
Bio-IT World
February 2007
Kevin Davies |
Obama Declares for Personalized Medicine Barack Obama is one of few members of congress who sees the genomics tidal wave and is doing something about it. Obama may be a Democrat, but drug and biotech industries have reason to hope. |
Chemistry World
October 10, 2006
Victoria Gill |
Pour-on Nanotechnology Stops Bleeding in Seconds Researchers at the Massachusetts Institute of Technology have created a liquid that stops bleeding in any tissue in a matter of seconds. It is a discovery that they claim has the potential to revolutionize surgery and emergency medicine and could even make it easier to reattach severed limbs. |
Bio-IT World
June 15, 2003
Kevin Davies |
The Overly Bold and the Beautiful For many (who really ought to know better), the temptation to fetishize DNA is all but irresistible. |
Bio-IT World
December 15, 2004
Kevin Davies |
First Trilogy Machine Installed at Mount Sinai A landmark installation for U.S. Genomics' Single Molecule Analyzer. |
Bio-IT World
January 12, 2004
Michael A. Greeley |
What You See Is What You Get Better image analysis, better business models. The transition from analog to digital will allow systems biology to reach its full potential. |
Technology Research News
June 29, 2005
Eric Smalley |
Cell combo yields blood vessels Researchers experiment with methods of getting blood vessels to grow in replacement organs before the tissue is placed in the body. |
Bio-IT World
January 13, 2003
John Dodge |
Talent Fuels Drug Pipeline in Swiss Time The functional genomics group has emerged as a critical link in the drug discovery chain at Novartis Pharmaceuticals Corp. While it employs a multidisciplinary approach to drug discovery, the four-year-old group's goals could not be simpler: Find novel drug targets. |
